Bronchiolitis, primarily caused by RSV, is a serious respiratory condition in infants that can lead to severe mucus build-up and breathing difficulties. Pediatrician Cindy Gellner, MD explains how ...
Nirsevimab therapy showed 83% effectiveness in preventing RSV-associated bronchiolitis hospitalizations in infants under 12 months. The study demonstrated significant efficacy against severe RSV cases ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results